J&J proposes $5.5 billion ovarian talc settlement contingent on 95% claimant participation

 

Johnson & Johnson proposes $5.5 billion ovarian talc settlement contingent on 95% claimant participation, with initial payment up to $3 billion in 2027

• Proposed settlement is described as comprehensive and would resolve remaining U.S. ovarian talc litigation claims.
• Under the proposal, no additional settlement payments would be due after the initial 2027 installment until 2028.

https://finviz.com/stock?t=JNJ&p=d